Management of resistant mucocutaneous herpes simplex infections in AIDS patients: a clinical and virological challenge

Barde, C; Piguet, Vincent; Pechere, Marc; Masouyé, Isabelle; Saurat, Jean-Hilaire; Wunderli, W; Kaiser, Laurent; Toutous Trellu, Laurence Marie

doi:10.1111/j.1468-1293.2010.00896.x

Scientific article

English

Management of resistant mucocutaneous herpes simplex infections in AIDS patients: a clinical and virological challenge

ContributorsBarde, C; Piguet, Vincent; Pechere, Marc; Masouyé, Isabelle; Saurat, Jean-Hilaire; Wunderli, W; Kaiser, Laurent; Toutous Trellu, Laurence Marie

Published inHIV medicine, vol. 12, no. 6, p. 367-373

Publication date2011

Abstract

The use of highly active antiretroviral therapy (HAART) has been associated with a marked decrease in the prevalence of opportunistic infections in HIV-infected patients. However, chronic mucocutaneous herpes simplex virus (HSV) infection remains a difficult clinical challenge.

Keywords

AIDS-Related Opportunistic Infections/complications/drug therapy/immunology/therapy
Acquired Immunodeficiency Syndrome/complications/drug therapy/immunology
Adult
CD4 Lymphocyte Count
Female
Herpes Genitalis/complications/drug therapy/immunology/therapy
Herpesvirus 2, Human/drug effects/immunology
Humans
Male
Middle Aged

Affiliation entities

Research groups

Virologie clinique (668)

Citation (ISO format)

BARDE, C et al. Management of resistant mucocutaneous herpes simplex infections in AIDS patients: a clinical and virological challenge. In: HIV medicine, 2011, vol. 12, n° 6, p. 367–373. doi: 10.1111/j.1468-1293.2010.00896.x

Article (Published version)

Identifiers

PID : unige:25305
DOI : 10.1111/j.1468-1293.2010.00896.x
PMID : 21251181

Journal ISSN1464-2662

715views

1037downloads

Creation22/10/2012 15:35:00

First validation22/10/2012 15:35:00

Update09/02/2026 15:43:39

Status update09/02/2026 15:43:39

Last indexation09/02/2026 15:46:43

Archive ouverte UNIGE

Management of resistant mucocutaneous herpes simplex infections in AIDS patients: a clinical and virological challenge

The use of highly active antiretroviral therapy (HAART) has been associated with a marked decrease in the prevalence of opportunistic infections in HIV-infected patients. However, chronic mucocutaneous herpes simplex virus (HSV) infection remains a difficult clinical challenge.

Technical informations